Literature DB >> 16098299

Relation of anemia at discharge to survival after acute coronary syndromes.

Joseph Vaglio1, David M Safley, Mohamed Rahman, Mikhail Kosiborod, Philip Jones, Randall Thompson, Harlan M Krumholz, John A Spertus.   

Abstract

Two-year survival rate was assessed among 1,038 patients who had acute coronary syndromes that were classified by discharge hematocrit values as normal (>39%, n = 360, 34.7%), mildly anemic (33.1% to 39%, n = 430, 41.4%), or moderately/severely anemic (< or = 33%, n = 248, 23.9%). Worsening anemia was associated with a decreased 2-year survival rate (normal 95.8%, mild anemia 91.2%, moderate/severe anemia 81.5%, p < 0.001). In multivariable analyses, adjusted hazard ratios for all-cause mortality were 1.57 (95% confidence interval 0.82 to 2.96) for mild anemia and 2.46 (95% confidence interval 1.25 to 4.85) for moderate/severe anemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098299     DOI: 10.1016/j.amjcard.2005.04.008

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction.

Authors:  Adam C Salisbury; Karen P Alexander; Kimberly J Reid; Frederick A Masoudi; Saif S Rathore; Tracy Y Wang; Richard G Bach; Steven P Marso; John A Spertus; Mikhail Kosiborod
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-05-20

2.  Baseline Hemoglobin Levels Associated with One-Year Mortality in ST-Segment Elevation Myocardial Infarction Patients.

Authors:  Cheng-Wei Liu; Pen-Chih Liao; Kuo-Chin Chen; Jung-Cheng Hsu; Ai-Hsien Li; Chung-Ming Tu; Yen-Wen Wu
Journal:  Acta Cardiol Sin       Date:  2016-11       Impact factor: 2.672

3.  Gamma interferon suppresses erythropoiesis via interleukin-15.

Authors:  Isis K Mullarky; Frank M Szaba; Lawrence W Kummer; Lindsey B Wilhelm; Michelle A Parent; Lawrence L Johnson; Stephen T Smiley
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

4.  Anemia status, hemoglobin concentration and outcome after acute stroke: a cohort study.

Authors:  David Tanne; Noa Molshatzki; Oleg Merzeliak; Rakefet Tsabari; Maya Toashi; Yvonne Schwammenthal
Journal:  BMC Neurol       Date:  2010-04-09       Impact factor: 2.474

Review 5.  Anemia and blood transfusion: prognostic implications in patients undergoing contemporary percutaneous coronary intervention.

Authors:  Mauro Moscucci
Journal:  Curr Cardiol Rep       Date:  2009-09       Impact factor: 2.931

6.  Gender differences in the association between discharge hemoglobin and 12-month mortality after acute myocardial infarction.

Authors:  Lauren E Thompson; Frederick A Masoudi; Kensey L Gosch; Pamela N Peterson; Philip G Jones; Adam C Salisbury; Mikhail Kosiborod; Stacie L Daugherty
Journal:  Clin Cardiol       Date:  2017-12-16       Impact factor: 2.882

7.  Predicting Adverse Outcomes After Myocardial Infarction Among Patients With Diabetes Mellitus.

Authors:  Suzanne V Arnold; John A Spertus; Philip G Jones; Darren K McGuire; Kasia J Lipska; Yaping Xu; Joshua M Stolker; Abhinav Goyal; Mikhail Kosiborod
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-05-24

Review 8.  Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment.

Authors:  Leila Fernandes Araujo; Alexandre de Matos Soeiro; Juliano Lara Fernandes; Antônio Eduardo Pesaro; Carlos V Serrano
Journal:  Vasc Health Risk Manag       Date:  2006

9.  [Impact of anaemia on the prognosis of myocardial infarction in black Africans].

Authors:  C Konin; M Adoh; J Koffi; J B Anzouan-Kacou; A Adoubi; E Kramoh; E Ake-Traboulsy
Journal:  Cardiovasc J Afr       Date:  2009 Jul-Aug       Impact factor: 1.167

10.  Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry.

Authors:  Yasuhiro Hamatani; Yugo Yamashita; Masahiro Esato; Yeong-Hwa Chun; Hikari Tsuji; Hiromichi Wada; Koji Hasegawa; Mitsuru Abe; Gregory Y H Lip; Masaharu Akao
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.